CINECA IRIS Institutional Research Information System

STELLA, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.184
EU - Europa 4.953
AS - Asia 1.995
AF - Africa 50
SA - Sud America 44
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 20
Totale 13.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.110
IT - Italia 1.267
CN - Cina 936
RU - Federazione Russa 641
IE - Irlanda 638
SE - Svezia 529
FR - Francia 474
SG - Singapore 378
FI - Finlandia 323
DE - Germania 300
UA - Ucraina 278
KR - Corea 243
GB - Regno Unito 133
PL - Polonia 123
AT - Austria 114
VN - Vietnam 89
IN - India 86
JP - Giappone 78
CA - Canada 62
ID - Indonesia 54
ES - Italia 31
TW - Taiwan 29
BR - Brasile 22
EU - Europa 21
HK - Hong Kong 20
BE - Belgio 19
NL - Olanda 17
IR - Iran 16
TR - Turchia 16
AU - Australia 15
RO - Romania 15
MA - Marocco 13
MX - Messico 12
SN - Senegal 12
DZ - Algeria 11
NO - Norvegia 11
UZ - Uzbekistan 10
CO - Colombia 9
PT - Portogallo 8
CH - Svizzera 7
TH - Thailandia 7
EG - Egitto 6
PK - Pakistan 6
IL - Israele 5
NZ - Nuova Zelanda 5
AR - Argentina 4
CL - Cile 4
GR - Grecia 4
JO - Giordania 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
IQ - Iraq 3
LK - Sri Lanka 3
RS - Serbia 3
SA - Arabia Saudita 3
SI - Slovenia 3
BF - Burkina Faso 2
CY - Cipro 2
EC - Ecuador 2
HU - Ungheria 2
LT - Lituania 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
LB - Libano 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
PH - Filippine 1
QA - Qatar 1
Totale 13.268
Salva come PNG Salva come JPEG
Città #
Chandler 732
Dublin 638
Beijing 434
Torino 418
Fairfield 344
Jacksonville 322
Ann Arbor 317
Ashburn 316
Houston 304
Singapore 287
Villeurbanne 258
Wilmington 237
Woodbridge 218
Medford 199
Princeton 189
Columbus 168
Nyköping 160
Seattle 153
Dearborn 152
Cambridge 131
Warsaw 118
Vienna 110
Pisa 92
Boston 77
Redwood City 67
Turin 54
Boardman 47
Dong Ket 46
Milan 46
Jakarta 44
Rome 43
Guangzhou 42
Shanghai 42
Norwalk 38
Hangzhou 36
Fremont 31
San Diego 30
Nanjing 29
Verona 27
Hefei 26
Santa Clara 26
Munich 23
Shenyang 22
Taipei 22
New York 21
San Mateo 21
Toronto 21
Zhengzhou 20
Düsseldorf 17
London 17
Paris 16
Brussels 15
Lappeenranta 15
Ottawa 15
Phoenix 15
Fuzhou 13
Jinan 13
Tokyo 13
Washington 13
Chengdu 12
Helsinki 12
Kunming 12
Xian 12
Falls Church 11
Pune 11
Siena 10
Upper Marlboro 10
Genova 9
Hebei 9
Mumbai 9
Oslo 9
Reims 9
Vancouver 9
Wuhan 9
Bologna 8
Gif-sur-yvette 8
Seoul 8
Suri 8
Catania 7
Harbin 7
Hong Kong 7
Parma 7
Brisbane 6
Buffalo 6
Detroit 6
Groningen 6
Montreal 6
Moscow 6
Nanchang 6
Pescara 6
Piemonte 6
Taglio Di Po 6
Bogotá 5
Caluire-et-Cuire 5
Changsha 5
Chicago 5
Loreto 5
Lyon 5
Manchester 5
Mountain View 5
Totale 7.673
Salva come PNG Salva come JPEG
Nome #
Nanostructured delivery systems with improved leishmanicidal activity: a critical review 790
Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts 287
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors 254
Caratterizzazione di nanoparticelle di polialchilcianoacrilato coniugate con l’acido folico 253
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes 195
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. 186
Pentamidine-Loaded Lipid and Polymer Nanocarriers as Tunable Anticancer Drug Delivery Systems 179
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells 178
Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative 175
Hyaluronan-decorated liposomes as drug delivery systems for cutaneous administration 161
Preparazione e caratterizzazione di liposomi convenzionali ed a lunga circolazione contenenti taxani 160
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 156
Advances in anticancer antibody-drug conjugates and immunotoxins. 154
A unique squalenoylated and non pegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity 153
Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives. 150
Nanoparticles obtained by confined impinging jet mixer: poly(lactide-co-glycolide) vs. Poly-ε-caprolactone 150
Cyclopamine-paclitaxel-containing nanoparticles: internalization in cells detected by confocal and super-resolution microscopy 149
Ruthenium polypyridyl squalene derivative: a novel self-assembling lipophilic probe for cellular imaging 146
Peptide conjugation: before or after nanoparticle formation? 139
Hyaluronic acid-coated liposomes for active targeting of gemcitabine. 138
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery 138
Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells 136
In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better. 128
Targeted Cancer Therapy: The Roles Played by Antibody-Drug and Antibody-Toxin Conjugates 119
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 117
Use of squalenic acid for the formulation of an active principle in nanoparticle state 116
Nonpolymeric nanoassemblies for ocular administration of acyclovir: pharmacokinetic evaluation in rabbits 116
Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice 115
Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment 109
Production of PEGylated nanocapsules through solvent displacement in confined impinging jet mixers 107
Nanoparticles of therapeutic agents having low water solubility 104
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles 99
Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates 99
Preparazione e caratterizzazione di liposomi convenzionali e a lunga circolazione contenenti taxani 98
Self-assembly drug conjugates for anticancer treatment 96
Anticancer prodrugs: an overview of major strategies and recent developments. 93
Effects of the Molecular Weight of Hyaluronic Acid in a Carbon Nanotube Drug Delivery Conjugate 92
Biological characterization of folic acid-conjugated poly(H(2)NPEGCA-co-HDCA) nanoparticles in cellular models 89
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain 88
Investigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy 87
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity. 86
Characterisation of folic acid-nanoparticles conjugates for tumoral targeting 84
Active targeting of squalenic nanoparticles 83
Hyaluronic acid for anticancer drug and nucleic acid delivery 82
Veicolazione di taxani in liposomi convenzionali ed a lunga circolazione 80
Biodegradable nanoparticles for drug delivery and targeting 79
Strategies to control the particle size distribution of doxorubicin-containing polycyanoacrylate nanoparticles 78
Disulfiram liposomiale: una nuova strategia contro l’adenocarcinoma duttale del pancreas. 78
Biological characterisation of folic acid-conjugated nanoparticles in cellular models 77
Elaboration of argan oil nanocapsules containing naproxen for cosmetic and transdermal local application 77
Gemcitabine derivatives nanoparticles 75
Cyclopamine-paclitaxel containing nanoparticles: internalization detection by confocal microscopy and super-resolution 74
Stacking as a key property for creating nanoparticles with tunable shape: The case of squalenoyl-doxorubicin 74
Targeting of squalene nanoparticles 73
Uptake and intracellular fate of biocompatible nanocarriers in cycling and noncycling cells 73
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 72
Design of folic acid-conjugated nanoparticles for drug targeting 71
Synthesis, characterization and biological evaluation of new PEG-paclitaxel derivatives. 71
Nanoparticle derivatives of gemcitabine 71
Exploiting lipid and polymer nanocarriers to improve the anticancer sonodynamic activity of chlorophyll 71
Squalenizzazione: nuova tecnica per nanoparticelle non polimeriche. 70
Developing actively targeted nanoparticles to fight cancer: Focus on italian research 70
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization 69
Effect of mixing in the preparation of doxorubicin-loaded cyanoacrylate nanoparticles via solvent displacement 69
Transfezione genica con vettori non virali 69
Squalene-doxorubicin: nanoassembly with superior anticancer activity and reduced toxicity. 69
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 69
New difluoro-2'-deoxycytidine derivatives, useful as anticancer and antiviral agents, contain residue that promotes formation of nanoparticles and increases stability in serum 68
Nonpolymeric nanoparticles for ocular administration of acyclovir 68
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 67
Hyaluronic acid-modified liposomes: preparation and preliminary biological characterization. 66
Preparazione e direzionamento attivo di nanoparticelle biodegradabili ad emivita plasmatica prolungata per la somministrazione di sostanze ad attività antitumorale 65
Hyaluronan liposomes for antitumor drug delivery 65
Characterisation of folic acid-conjugated nanoparticles for tumoral targeting 65
Nanoparticles of Therapeutic agents having low water solubility (US extension) 65
Detection of flourescent nanoparticles containing squalene-cyclopamine and squalene-paclitaxel 65
Preparation of P(MePEGCA-co-HDCA) nanoparticles loaded with doxorubicin: mixing issues 64
Continuous production of polymeric nanocapsules through confined impinging jets mixers 64
Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse (JP extension) 63
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 63
Multifunctional squalenoyl nanocomposites for pancreatic cancer: diagnostic and therapeutic aspects 62
Preparation and characterization of novel PEG-paclitaxel derivatives 62
Incorporation and release of gemcitabine prodrug in mesoporous silica nanoparticles 62
Gemcitabine derivatives nanoparticles 61
Gemcitabine derivatives nanoparticles 61
Ciblage tumorale intracellulaire à l’aide de l’acide folique couplé aux nanoparticules ‘peggylées’ 60
Nanoparticles of Gemcitabine derivatives 60
NANOPARTICLES OF THERAPEUTIC AGENTS HAVING LOW WATER SOLUBILITY 60
Nanoparticles of therapeutic agents having low water solubility 60
Fluorescence and electron microscopy to visualize the intracellular fate of nanoparticles for drug delivery 60
Zeta potential measurements on solid surfaces for in Vitro biomaterials testing: Surface charge, reactivity upon contact with fluids and protein absorption 60
An ex vivo experimental system to track fluorescent nanoparticles inside skeletal muscle 59
Nanomedicine for gene delivery and drug repurposing in the treatment of muscular dystrophies 59
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 58
Incorporation of lipophilic gemcitabine prodrugs in liposomes 58
Novel nanoassemblies of potent anticancer compounds by conjugation with squalene moiety 58
Incorporation of squalenoyl doxorubicin into solid lipid nanoparticles 58
New difluoro-2'-deoxycytidine derivatives, useful as anticancer and antiviral agents, contain residue that promotes formation of nanoparticles and increases stability in serum 57
Preparazioni liposomiali utilizzate in oncologia medica 56
Gemcitabine derivatives nanoparticles 56
Totale 10.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.169
article - articoli 0
book - libri 0
conference - conferenze 16.627
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.796
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.205 0 0 0 0 83 228 194 126 210 173 102 89
2020/20211.717 191 100 131 66 144 85 205 68 215 170 162 180
2021/20222.067 64 79 68 163 89 80 145 159 58 129 612 421
2022/20232.391 236 148 51 217 215 658 270 134 244 43 126 49
2023/20241.147 108 208 78 68 81 119 52 61 14 92 94 172
2024/20251.257 654 167 112 252 72 0 0 0 0 0 0 0
Totale 13.807